Question

Difficulty: MediumPsychopharmacology and Psychological Therapies

A consultation-liaison psychiatry team is reviewing common adverse effects of various psychotropic medications to update hospital safety protocols. Match each clinical presentation of an adverse drug reaction with the medication most likely responsible.

  • Polyuria, polydipsia, new-onset fine tremor, and elevated thyroid-stimulating hormone (TSH).Lithium
  • Excessive sialorrhea, generalized tonic-clonic seizures, and severe neutropenia.Clozapine
  • Rapidly spreading maculopapular exanthem with oral mucosal blistering and epidermal detachment.Lamotrigine
  • Acute altered mental status, asterixis, and hyperammonemia in the setting of elevated transaminases.Valproate

Answer

The presentations match as follows: polyuria/tremor/hypothyroidism with Lithium; sialorrhea/seizures/neutropenia with Clozapine; mucosal blistering rash with Lamotrigine; and hyperammonemic encephalopathy with Valproate.
Each psychotropic medication has a distinct adverse effect profile that is critical for clinical monitoring. Lithium causes nephrogenic diabetes insipidus and hypothyroidism. Clozapine causes agranulocytosis and lowers the seizure threshold. Lamotrigine can cause Stevens-Johnson syndrome. Valproate can cause hyperammonemic encephalopathy and hepatotoxicity.

Step-by-Step Solution

1
Analyze the first clinical presentation (polyuria, tremor, elevated TSH).
Identified as lithium-induced adverse effects.
Lithium affects renal concentrating ability (nephrogenic DI) and thyroid gland function, and commonly causes a fine tremor.
2
Analyze the second presentation (sialorrhea, seizures, neutropenia).
Identified as clozapine toxicity.
Clozapine is unique among antipsychotics for causing agranulocytosis, hypersalivation, and a significantly increased risk of seizures.
3
Analyze the third presentation (mucosal blistering, epidermal detachment).
Identified as Stevens-Johnson syndrome/Toxic epidermal necrolysis caused by lamotrigine.
Lamotrigine is strongly associated with life-threatening rashes, particularly if titrated too rapidly.
4
Analyze the fourth presentation (hyperammonemia, hepatotoxicity, asterixis).
Identified as valproate-induced hyperammonemic encephalopathy.
Valproate interferes with the urea cycle, leading to hyperammonemia and subsequent encephalopathy presenting with asterixis.

Key Concept

Adverse effect profiles of psychotropic medications
Rate this question